Publication Date:
This Advisory examines the role of genetic testing in assessing SUD vulnerability and outlines the current limitations of these technologies.
Publication Date:
This advisory introduces readers to digital therapeutics (DTx) and the benefits of their use in behavioral health. It describes the research, regulatory, and reimbursement implications for DTx as well as selection and implementation considerations.
Publication Date:
This advisory introduces readers to cannabidiol (CBD), how it is derived, and how it differs from delta-9 THC and other cannabinoids. The advisory focuses on the risks and harms of CBD, especially those sold over the counter. This advisory also clarifies common misconceptions about CBD, given its broad availability and marketing for several medical conditions despite limited evidence of efficacy.
Publication Date:
This resource provides information to primary care providers and practices on how to implement opioid use disorder treatment using buprenorphine. It identifies common barriers and strategies to overcome them. It documents step-by-step tactics to support buprenorphine implementation.
Publication Date:
This document evaluates states’ use of best practices in preventing underage drinking, as required by the STOP Act.
Publication Date:
This Treatment Improvement Protocol (TIP) reviews the use of the three Food and Drug Administration (FDA)-approved medications used to treat OUD—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery for people with OUD
Publication Date:
This guide reviews ways that telehealth modalities can be used to provide treatment for serious mental illness and substance use disorders among adults, distills the research into recommendations for practice, and provides examples of how these recommendations can be implemented.
Publication Date:
This Advisory is based on TIP 31, Screening and Assessing Adolescents for Substance Use Disorders (SUDs) and TIP 32, Treatment of Adolescents with SUDs. It includes recommendations for engaging adolescents in SUD risk assessment, screening, and treatment.
Publication Date:
This Advisory is based on TIP 50, Addressing Suicidal Thoughts and Behaviors in Substance Abuse Treatment. It provides strategies for identifying and addressing suicidal thoughts and behaviors among individuals with substance use disorders (SUDs).
Publication Date:
This guide reviews interventions for people living with substance use and mental disorders who are at risk for or living with HIV. Selected interventions are in alignment with goals of the federal “Ending the HIV Epidemic: A Plan for America” (EHE) initiative.
Publication Date:
This CDC Resource offers Community Preventive Services Task Force recommendations and evidence ratings on regulation of alcohol outlet density, taxes, dram shop liability, sales, electronic screening, and minor sales.
Publication Date:
This guide supports health care providers, systems, and communities seeking to prevent vaping. It describes relevant research findings, examines emerging and best practices, identifies knowledge gaps and implementation challenges, and offers useful resources.
Publication Date:
This guide supports health care providers, systems, and communities seeking to treat stimulant use disorders. It describes relevant research findings, examines emerging and best practices, identifies knowledge gaps and implementation challenges, and offers useful resources.
Publication Date:
This guide from the American Society of Addiction Medicine (ASAM) includes information on assessment, treatment overview (including treatment plans, patient participation, and counseling), and all the medications available to treat opioid use and overdose. It also provides links to find a provider and support groups for patients and families.
Publication Date:
This National Practice Guideline (NPG) pocket guide from the American Society of Addiction Medicine (ASAM) is intended to aid clinicians in their clinical decision-making and patient management. The NPG pocket guide strives to identify and define clinical decision-making junctures that meet the needs of most patients in most circumstances.
Publication Date:
This toolkit provides correctional administrators and health care providers recommendations and tools for implementing medication-assisted treatment (MAT) in correctional settings. It provides examples from the field that can be widely applied and adapted for programs that serve justice-involved individuals.
Publication Date:
The ASAM Clinical Practice Guideline on Alcohol Withdrawal Management is intended to aid clinicians in their clinical decision-making and management of patients experiencing alcohol withdrawal syndrome.
Publication Date:
This guide developed by the American Society of Addiction Medicine (ASAM) provides healthcare providers with instant access to current guidelines in a clear concise format.
Publication Date:
The National Practice Guideline (NPG) from the American Society of Addiction Medicine (ASAM) is intended to inform and empower clinicians, health system administrators, criminal justice system administrators, and policymakers who are interested in implementing evidence-based practices to improve outcomes for individuals with opioid use disorder.
Publication Date:
This guide helps clinicians influence the change process in their clients by incorporating motivational interventions into substance use disorder treatment programs.
Publication Date:
This guide provides school leaders and administrators with key information regarding a broad range of student assistance services. It addresses school connectedness, substance use, mental health promotion, and violence prevention. The guide includes information about effective planning, implementation, evaluation, and sustainability of student assistance programs in disparate settings.
Publication Date:
Chronic pain is common, multidimensional, and individualized, and treatment can be challenging for healthcare providers as well as patients. In response to the critical need for consistent and current opioid prescribing guidelines, the CDC released the Guideline for Prescribing Opioids for Chronic Pain.
Publication Date:
This guide examines a wide range of evidence-based practices for screening and assessment of people in the justice system who have co-occurring mental and substance use disorders.
Publication Date:
This document provides state by state information on implementation of intensive care coordination using a wraparound approach for children and youth with complex mental and substance use disorders.
Publication Date:
This tool guides clinicians through a series of questions to identify risky substance use in their adult patients. The accompanying resources assist clinicians in providing patient feedback and arranging for specialty care, where necessary, using the 5 As of intervention.
Displaying 1 - 25 out of 60